Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gore

Showing results (801-810 of 833) with videos related to

Pageof 84
Sort By:
JAMA|June 10, 2004
A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registryKim A Eagle, Michael J Lim, Omar H Dabbous, et al.
Journal of Atrial Fibrillation|July 11, 2018
Recent Trends in Oral Anticoagulant Use and Post-Discharge Complications Among Atrial Fibrillation Patients with Acute Myocardial InfarctionAmartya Kundu, Kevin O Day, Darleen M Lessard, et al.
The American Journal of Cardiology|August 18, 2018
Previous and New Onset Atrial Fibrillation and Associated Outcomes in Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events)Mali D Worme, Mary K Tan, David W J Armstrong, et al.
American Journal of Clinical Oncology|May 22, 2012
ACR Appropriateness Criteria® follow-up and retreatment of brain metastasesSamir H Patel, Jared R Robbins, Elizabeth M Gore, et al.
JAMA Ophthalmology|June 28, 2019
Genetic Variants Associated With Corneal Biomechanical Properties and Potentially Conferring Susceptibility to Keratoconus in a Genome-Wide Association StudyAnthony P Khawaja, Karla E Rojas Lopez, Alison J Hardcastle, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 21, 2017
Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839Martin J Edelman, Chen Hu, Quynh-Thu Le, et al.
American Heart Journal|September 29, 2009
Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registryJason N Katz, Joel M Gore, Alpesh Amin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910Thomas M Pisansky, Daniel Hunt, Leonard G Gomella, et al.
Urologic Oncology|July 7, 2016
Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01Raymond H Mak, Daniel Hunt, Jason A Efstathiou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2020
The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancersG Saturno, F Lopes, I Niculescu-Duvaz, et al.
Pageof 84

Showing results (801-810 of 833) with videos related to

Sort By:
Pageof 84
JAMA|June 10, 2004
A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registryKim A Eagle, Michael J Lim, Omar H Dabbous, et al.
Journal of Atrial Fibrillation|July 11, 2018
Recent Trends in Oral Anticoagulant Use and Post-Discharge Complications Among Atrial Fibrillation Patients with Acute Myocardial InfarctionAmartya Kundu, Kevin O Day, Darleen M Lessard, et al.
The American Journal of Cardiology|August 18, 2018
Previous and New Onset Atrial Fibrillation and Associated Outcomes in Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events)Mali D Worme, Mary K Tan, David W J Armstrong, et al.
American Journal of Clinical Oncology|May 22, 2012
ACR Appropriateness Criteria® follow-up and retreatment of brain metastasesSamir H Patel, Jared R Robbins, Elizabeth M Gore, et al.
JAMA Ophthalmology|June 28, 2019
Genetic Variants Associated With Corneal Biomechanical Properties and Potentially Conferring Susceptibility to Keratoconus in a Genome-Wide Association StudyAnthony P Khawaja, Karla E Rojas Lopez, Alison J Hardcastle, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 21, 2017
Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839Martin J Edelman, Chen Hu, Quynh-Thu Le, et al.
American Heart Journal|September 29, 2009
Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registryJason N Katz, Joel M Gore, Alpesh Amin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910Thomas M Pisansky, Daniel Hunt, Leonard G Gomella, et al.
Urologic Oncology|July 7, 2016
Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01Raymond H Mak, Daniel Hunt, Jason A Efstathiou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2020
The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancersG Saturno, F Lopes, I Niculescu-Duvaz, et al.
Pageof 84